186 related articles for article (PubMed ID: 22479620)
1. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
Nie W; Li B; Xiu QY
PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen Activator Inhibitor-1 4G/5G Polymorphism Contributes to Osteonecrosis of the Femoral Head Susceptibility: Evidence from a Systematic Review and Meta-analysis.
Sobhan MR; Mahdinezhad-Yazdi M; Moghimi M; Aghili K; Jafari M; Zare-Shehneh M; Neamatzadeh H
Arch Bone Jt Surg; 2018 Nov; 6(6):468-477. PubMed ID: 30637301
[TBL] [Abstract][Full Text] [Related]
3. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
Zhang TT; Yuan L; Yang YM; Ren Y
Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
[TBL] [Abstract][Full Text] [Related]
4. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
[TBL] [Abstract][Full Text] [Related]
5. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
6. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
Zhang X; Gao B; Xu B
Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
[TBL] [Abstract][Full Text] [Related]
7. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
[TBL] [Abstract][Full Text] [Related]
8. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
Zhao L; Bracken MB; Dewan AT; Chen S
Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
[TBL] [Abstract][Full Text] [Related]
9. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.
Wei Z; Chang K; Fan C
Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365
[TBL] [Abstract][Full Text] [Related]
10. PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies.
Zheng L; Li X; Song Q; Hou C; Chen X; Li B
Int Arch Allergy Immunol; 2019; 180(4):255-263. PubMed ID: 31574527
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
12. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
[TBL] [Abstract][Full Text] [Related]
13. Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: a meta-analysis.
Liang XN; Xie L; Cheng JW; Tan Z; Yao J; Liu Q; Su W; Qin X; Zhao JM
Thromb Res; 2013 Aug; 132(2):158-63. PubMed ID: 23856555
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor-1 4G/5G polymorphism and ischemic stroke risk: a meta-analysis in Chinese population.
Cao Y; Chen W; Qian Y; Zeng Y; Liu W
Int J Neurosci; 2014 Dec; 124(12):874-81. PubMed ID: 24472072
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
[TBL] [Abstract][Full Text] [Related]
17. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients.
Pampuch A; Kowal K; Bodzenta-Lukaszyk A; Di Castelnuovo A; Chyczewski L; Donati MB; Iacoviello L
Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.
Zhang T; Pang C; Li N; Zhou E; Zhao K
BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 gene polymorphism 4G/4G genotype and lupus nephritis in Chinese patients.
Wang AY; Poon P; Lai FM; Yu L; Choi PC; Lui SF; Li PK
Kidney Int; 2001 Apr; 59(4):1520-8. PubMed ID: 11260416
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
Ma Z; Paek D; Oh CK
Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]